Novartis In our last meeting, you said that you were looking forward to a decade of continuous growth and to be the number one partner of choice for patients, physicians, governments and institutions. In what way have you been able to do that? Novartis Colombia has a broader portfolio compared to…
Novartis Belgium Mrs van der Kamp, you launched your career as a strategy consultant however, since then you have moved into the pharmaceutical industry by joining Novartis where you quickly worked your way up the ladder. What attracted you to this industry and Novartis specifically? Prior to beginning my career as a…
Array After just six months in the country, Novartis Australia’s new Managing Director offers his perspectives on the Australian pharmaceutical market and healthcare system, his company’s commitment to R&D, and Australia’s competitiveness for clinical trials in the Asian context. You arrived in July 2012 after working in different positions for…
Novartis South Africa Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what were the surprises for you in South Africa? Because of my previous exposure to various markets, I was anxious about what I would find…
Array As a Taiwanese national and Country Head of Novartis Taiwan, what is your opinion on the current state of the pharmaceutical industry in Taiwan, and what are your hopes for the future? I am of the opinion that it is going to get worse before it gets better. The National…
Novartis De Colombia S.A. Being an industry giant with operations in over one hundred counties worldwide, what is the role and significance of Colombia for Novartis global? As a global company, our overall mission is to discover, develop, and successfully market innovative products to prevent and cure diseases; to ease suffering; and to enhance…
Novartis Brazil The government recently released the BrasilMaior plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry here in Brazil? I think compared to, say, 10 years ago, the new government has understood that the pharmaceutical, biotech,…
Novartis France You worked for many years in emerging markets, especially in Latin America, but also in neighbor countries such as Spain. How these previous experiences in very different markets can now help you direct the world’s third largest pharmaceutical market? Experiencing different patterns, trends and types of businesses gives you a…
Novartis Argentina When we met with Javier Lombar at IMS Argentina, he was explaining how a lot of multinational companies are using Argentina as a regional base of operations. Novartis is a prime example of this. Could you explain how Novartis operates in a Latin American context, and what role the Argentinean…
Novartis Chile Novartis’ pharmaceutical activities include innovators, generics and biopharmaceuticals. How has your portfolio developed in Chile? What therapeutic areas is Novartis favoring in the Chilean context? Novartis is one of the Top 5 pharmaceutical companies at an international level. We have products in all the therapeutic areas inside the ethical pharmaceutical…
Novartis Farmaceutica S.A. de C.V. (Mexico) Carlos Garcia said in December 2009 that 6-8% of Novartis’ annual revenue comes from Latin America, and that the area is “one of the main growth engines for the company”. Can you tell us how Novartis Mexico fits in with that growth strategy? Mexico is the second biggest market in…
Novartis India Right after you started heading the India operations roughly 15 years ago, you had to oversee one the biggest mergers in the industry at that time. How challenging was that moment for you? Any merger has its set of challenges and opportunities, and I think you will always look more…
See our Cookie Privacy Policy Here
